ptc therapeutics cfo: rare potential | mad money | cnbc
Published 9 years ago • 2.5K plays • Length 6:24Download video MP4
Download video MP3
Similar videos
-
4:43
acorda therapeutics ceo: high-powered biotech | mad money | cnbc
-
6:14
intarcia therapeutics ceo: holy grail of disease treatment | mad money | cnbc
-
6:06
cara therapeutics ceo: battling opioids | mad money | cnbc
-
7:16
therapeuticsmd chairman & ceo: redefining women’s health | mad money | cnbc
-
5:54
tg therapeutics ceo: cancer-fighting biotech | mad money | cnbc
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
7:27
jim cramer: roth or traditional account? | archives | cnbc
-
6:41
former fda commissioner dr. scott gottlieb on the future of gene therapy
-
6:43
therapeuticsmd ceo: strides for women’s health | mad money | cnbc
-
5:44
tg therapeutics ceo: finding the right price | mad money | cnbc
-
6:04
karyopharm therapeutics ceo: combatting cancer | mad money | cnbc
-
6:10
intarcia therapeutics ceo: disrupting diabetes | mad money | cnbc
-
6:35
prothena corporation ceo: biotech breakthrough | mad money | cnbc
-
6:58
novocure chairman: two-pronged opportunity | mad money | cnbc
-
6:37
novocure ceo: electrifying treatment | mad money | cnbc
-
6:57
dr. eric topol: the future of democratized medicine | mad money | cnbc
-
6:08
cellectis ceo: creating a cancer fighting machine | mad money | cnbc
-
45:51
webinar: a conversation with ptc therapeutics (dec 2022)
-
7:00
esperion therapeutics ceo tim mayleben | mad money | cnbc
-
7:02
sage therapeutics ceo: challenging conventional wisdom | mad money | cnbc
-
5:27
crispr therapeutics ceo talks winning fda approval for sickle cell anemia treatment
-
6:07
mallinckrodt to buy questcor | mad money | cnbc